Eikon Therapeutics, Inc. (EIKN)
NASDAQ: EIKN · Real-Time Price · USD
13.80
-1.08 (-7.26%)
At close: Mar 3, 2026, 4:00 PM EST
13.78
-0.02 (-0.14%)
After-hours: Mar 3, 2026, 7:43 PM EST
Eikon Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$25.60
Upside
+85.51%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 2, 2026 |
| JP Morgan | JP Morgan | Buy Initiates $29 | Buy | Initiates | $29 | +110.14% | Mar 2, 2026 |
| B of A Securities | B of A Securities | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | +146.38% | Mar 2, 2026 |
| Mizuho | Mizuho | Buy Initiates $26 | Buy | Initiates | $26 | +88.41% | Mar 2, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $32 | Buy | Initiates | $32 | +131.88% | Mar 2, 2026 |
| Wedbush | Wedbush | Sell Initiates $7 | Sell | Initiates | $7 | -49.28% | Feb 26, 2026 |